Protea Biosciences

Founded in 2001, Protea Biosciences was the first biotechnology company in West Virginia, created to commercialize new technologies from West Virginia University (WVU). The company's core mission is to advance bioanalytical technology, with a vision to revolutionize molecular analysis and mapping. Protea offers a range of products and services, including the groundbreaking Protea LAESI DP-1000 direct ionization system, a state-of-the-art Bioanalytical Services laboratory, and various mass spectrometry and protein sample preparation products. Their market focus is on providing innovative solutions for biologists and biochemists globally.

Notable affiliated individuals include key researchers and technologists from WVU, who have played significant roles in the company's development. Protea has attracted investments from biotech-focused venture capital firms and strategic partners. Key achievements include the successful commercialization of their LAESI technology and establishing themselves as an industry leader in bioanalytics. The overall impact of Protea Biosciences lies in its contribution to advancing molecular analysis techniques, thereby facilitating significant scientific discoveries and innovations in the field of biotechnology.